Geber86/E+ via Getty Images Intelligent Bio Solutions ( NASDAQ: INBS ) on Thursday said that it has signed two new major customer accounts within the UK warehouse and logistics sector within the past three months, sending shares up in early trade. Intelligent Bio ( INBS ) rose 3.70% pre-market $1.
96. These accounts employ more than 15,000 individuals at more than 70 locations and will adopt INBS’ Intelligent Fingerprinting Drug Screening System at the majority of their UK sites, Intelligent Bio Solutions ( INBS ) said. INBS' first-of-its-kind solution uses fingerprint sweat to provide a quick, and easy-to-use method for drug testing, delivering results in just minutes.
This unique approach tests for common drugs of abuse, including cocaine, cannabis, methamphetamine, and opiates, the company said. Source: Press Release More on Intelligent Bio Solutions Intelligent Bio Solutions expects approximate unaudited Q3 revenue of $0.82M Seeking Alpha’s Quant Rating on Intelligent Bio Solutions Historical earnings data for Intelligent Bio Solutions Financial information for Intelligent Bio Solutions.
